cgp 42112a has been researched along with amastatin in 1 studies
| Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (amastatin) | Trials (amastatin) | Recent Studies (post-2010) (amastatin) |
|---|---|---|---|---|---|
| 233 | 0 | 35 | 183 | 0 | 19 |
| Protein | Taxonomy | cgp 42112a (IC50) | amastatin (IC50) |
|---|---|---|---|
| Aminopeptidase N | Sus scrofa (pig) | 1.1 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guethe, LM; Juliano, MA; Martins, AR; Pelegrini-da-Silva, A; Prado, WA; Rosa, E | 1 |
1 other study(ies) available for cgp 42112a and amastatin
| Article | Year |
|---|---|
Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter.
Topics: Analgesics; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Disease Models, Animal; Drug Interactions; Efferent Pathways; Glutamyl Aminopeptidase; Losartan; Male; Microinjections; Neural Inhibition; Nociceptors; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptides; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, Angiotensin | 2009 |